| Moderate quality of evidence |
| Cibenzoline |
| Gatifloxacin |
| Pentamidine |
| Quinine |
| Indomethacin |
| Glucagon (during endoscopy) |
| Low quality of evidence |
| Chloroquineoxaline sulfonamide |
| Artesunate/artemisin/artemether |
| IGF-1 |
| Lithium |
| Propoxyphene/dextropropoxyphene |
| Very low quality of evidence |
| Drugs with >25 cases of hypoglycemia identified |
| Angiotensin-converting enzyme inhibitors |
| Angiotensin receptor antagonists |
| Beta-adrenergic receptor antagonists |
| Levofloxacin |
| Mifepristone |
| Disopyramide |
| Trimethoprim-sulfamethoxazole |
| Heparin |
| 6-mercaptopurine |
